“Living Drug Factories” Could Help Treat Many DiseasesNews
Chemical engineers have created a way to protect transplanted drug-producing cells from immune system rejection. The researchers hope that the technology could be used to treat many different diseases, including diabetes.READ MORE
Scientists Electrify Aluminum To Speed Up Drug ManufacturingNews
Scientists have found a way in the laboratory to shorten the time it takes to create a key chemical used to synthesize a variety of pharmaceuticals, fertilizers and other important substances.READ MORE
Researchers have discovered that, whilst amyloid plaque formation directly causes brain tissue loss in animal models, lithium can reduce the life-shortening effects of this loss.READ MORE
Researchers have found that the ABCC4 transporter is critical to the SHH signaling pathway in the brain tumor medulloblastoma – the most common malignant pediatric brain tumor.READ MORE
A team has developed a method for assembling hanging droplets that could assist chemical reactions in extremely small – less than 1 millimeter – spaces. This new method has potential to be applied to drug manufacturing.READ MORE
Purdue University researchers are working to move COVID-19 diagnostic and therapeutic solutions to the marketplace as soon as possible.READ MORE
When UC Davis announced the first case of community transmission of COVID-19 in the U.S. on Feb. 26, it solved a medical mystery at the hospital and led to important changes to the U.S. Centers for Disease Control and Prevention (CDC) guidelines for novel coronavirus testing.
Researchers led by biomedical engineers at Tufts University invented a microfluidic chip containing cardiac cells that is capable of mimicking hypoxic conditions following a heart attack - specifically when an artery is blocked in the heart and then unblocked after treatment.READ MORE
A first-of-its-kind trial has demonstrated that a receptor involved in the brain’s reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders. This innovative fast-fail trial was funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, and the results of the trial are published in Nature Medicine.
In a new article published online ahead of print in Cancer Research, scientists report the identification of potential therapeutic targets for cutaneous squamous cell carcinoma.READ MORE